AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) is projected to announce its Q4 2025 results before the market opens on Friday, March 13th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $34.93 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, March 20, 2026 at 8:00 AM ET.
AirSculpt Technologies Trading Up 17.7%
AirSculpt Technologies stock opened at $2.26 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.51 and a current ratio of 0.51. AirSculpt Technologies has a fifty-two week low of $1.51 and a fifty-two week high of $12.00. The stock has a market cap of $141.11 million, a P/E ratio of -7.53 and a beta of 2.75. The firm’s fifty day moving average price is $2.21 and its 200-day moving average price is $4.76.
Insider Buying and Selling
In related news, major shareholder Jorey Chernett acquired 88,000 shares of the company’s stock in a transaction dated Wednesday, March 11th. The stock was bought at an average cost of $2.15 per share, with a total value of $189,200.00. Following the acquisition, the insider owned 6,486,211 shares of the company’s stock, valued at approximately $13,945,353.65. The trade was a 1.38% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last three months, insiders have purchased 243,600 shares of company stock valued at $473,300. 76.58% of the stock is owned by insiders.
Institutional Trading of AirSculpt Technologies
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of AirSculpt Technologies in a research report on Monday, December 29th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $6.00.
View Our Latest Stock Analysis on AirSculpt Technologies
About AirSculpt Technologies
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
Featured Stories
- Five stocks we like better than AirSculpt Technologies
- The Next Commodity Crunch (bigger than oil?)
- What a Former CIA Agent Knows About the Coming Collapse
- The gold chart Wall Street is terrified of…
- I tried out Elon Musk’s new AI tech — it floored me
- “I just bought 10,000 shares of a $5 stock…”
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
